Peptide Knowledge Base · GH-axis

GHRP-6: what it is, what the evidence says, and its real status

An early GH-releasing peptide best known for a big hunger spike alongside the GH bump.

Can you actually get it?

Plain-English verdict: Education only.

Regulatory status: Expected to stay restricted.

How does GHRP-6 work?

A ghrelin-receptor agonist that releases growth hormone and markedly stimulates appetite.

What it does — and what it does not do

What it does: Raises GH and appetite; used historically in performance contexts.

What it does not do: It is not approved or available, and the appetite effect limits its appeal.

How honest is the evidence?

Evidence grade D — Animal and lab evidence; human trials still to come.

older data; strong appetite stimulation; restricted

A grade measures how much human evidence exists, not whether a molecule is good, safe, or worth your interest. Read our grading methodology for what each grade means.

What we still don't know: Long-term endocrine and metabolic effects are poorly characterized.

WADA status: Banned (S2).

Who should not take it

WADA S2 banned; appetite/cortisol effects; not characterized for safe human use.

Sources

GHRP-6 GH-secretagogue literature; FDA compounding restriction list

Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker for status.

Join the founding list →

Embed this card on your site · free, CC BY 4.0, no key.

Last reviewed Jun 18, 2026 · Peptós.LIFE · Not medical advice.